Your session is about to expire
← Back to Search
AVEED (Testosterone Undecanoate Injection) for Low Testosterone
Study Summary
This trial will study the effect of testosterone on blood pressure in males with primary or secondary hypogonadism. Testim®, Fortesta®, and Aveed® are all forms of testosterone treatment that will be applied or injected over the course of 16 weeks.
- Low Testosterone
- Testicular Hypogonadism
- Hypogonadotropic Hypogonadism
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has the FDA given its seal of approval to Testosterone undecanoate injection (AVEED)?
"There is a considerable amount of evidence confirming the safety profile of Testosterone undecanoate injection (AVEED), thus its score on our scale was 3 out 4. This is due to this particular intervention being approved for use in Phase 4 clinical trials."
What medical conditions is Testosterone undecanoate injection (AVEED) frequently prescribed for?
"Testosterone undecanoate injection (AVEED) is mostly used to treat post-menopausal women over the course of 1-5 years. It has also been brought into use to handle hypogonadotropic hypogonadism, orchidectomy and orchitis."
How many locations are overseeing the operation of this clinical trial?
"This experiment is being hosted at Endo Clinical Trial Site #30 in Beverly Hills, Florida, Endo Clinical Trial Site #31 in Houston, Texas, and Endo Clinical Trial Site #29 Fleming Island Maryland alongside 35 other trial sites."
Are there vacancies in the experiment for volunteers?
"Absolutely. According to the clinicaltrials.gov portal, this research effort is still seeking participants since its inception on June 30th 2020 and latest update on September 19th 2022. The study has a target of 618 enrollees across 35 medical facilities."
How many individuals have enrolled in the research protocol?
"Endo Pharmaceuticals, the trial sponsor, needs 618 qualified participants to run this clinical study. To facilitate that process they have opened two sites: Endo Clinical Trial Site #30 in Beverly Hills and Endo Clinical Trial Site #31 located in Houston."
Has Testosterone undecanoate injection (AVEED) been evaluated in any other studies?
"At present, there are 36 clinical studies in progress related to Testosterone undecanoate injection (AVEED). 5 of those trials are currently at the third phase; with most centered around Houston, Texas. All told, 135 medical centres across the US have opened their doors for this treatment program."
Who else is applying?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
What state do they live in?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Average response time
- < 2 Days
Typically responds via
Most responsive sites:
- Endo Clinical Trial Site #22: < 24 hours
- Endo Clinical Trial Site #21: < 48 hours
- Endo Clinical Trial Site #19: < 48 hours
Share this study with friends
Copy Link
Messenger